Pets At Home Group/£PETS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Pets At Home Group
Pets at Home Group PLC, founded in 1991, operates as a leading pet care brand in the UK. The company specializes in retailing pet food, pet products, accessories, and offering veterinary services across its widespread network of stores and online platforms. Pets at Home operates in a myriad of sectors including retail of pet supplies, veterinary care through its Vet Group, and grooming services, ensuring comprehensive care and products for pets and their owners.
- Ticker
- £PETS
- Sector
- Consumer Discretionary
- Primary listing
- LSE
- Employees
- 11,040
- Headquarters
- Handforth, United Kingdom
- Website
- www.petsathomeplc.com
PETS Metrics
BasicAdvanced
£1.2B
20.21
£0.14
1.08
£0.07
2.69%
Price and volume
Market cap
£1.2B
Beta
1.08
52-week high
£2.76
52-week low
£1.67
Average daily volume
1.3M
Dividend rate
£0.07
Financial strength
Current ratio
0.613
Quick ratio
0.239
Long term debt to equity
0.325
Total debt to equity
0.408
Dividend payout ratio (TTM)
93.92%
Interest coverage (TTM)
5.75%
Profitability
EBITDA (TTM)
141.1
Gross margin (TTM)
45.73%
Net profit margin (TTM)
4.25%
Operating margin (TTM)
7.43%
Effective tax rate (TTM)
27.05%
Revenue per employee (TTM)
£130,000
Management effectiveness
Return on assets (TTM)
4.12%
Return on equity (TTM)
6.42%
Valuation
Price to earnings (TTM)
20.206
Price to revenue (TTM)
0.85
Price to book
1.25
Price to tangible book (TTM)
-139.81
Price to free cash flow (TTM)
8.364
Free cash flow yield (TTM)
11.96%
Free cash flow per share (TTM)
0.329
Dividend yield (TTM)
2.69%
Growth
Revenue change (TTM)
-0.84%
Earnings per share change (TTM)
-27.66%
3-year revenue growth (CAGR)
1.53%
10-year revenue growth (CAGR)
6.36%
3-year earnings per share growth (CAGR)
-12.35%
10-year earnings per share growth (CAGR)
-0.64%
3-year dividend per share growth (CAGR)
-16.69%
10-year dividend per share growth (CAGR)
-0.13%
What the Analysts think about PETS
Analyst ratings (Buy, Hold, Sell) for Pets At Home Group stock.
Analyst projections of the future price of Pets At Home Group stock.
Bulls say / Bears say
Retail is showing signs of a turnaround: Q1 FY27 retail revenue rose 4.9%, volumes grew faster than sales and the company reported market-share gains. Management kept full-year guidance unchanged. (London Stock Exchange)
The vet business provides a growing, partly recurring earnings base: FY26 vet revenue rose 5% and profit increased 10.4%, supported by care plans and practice expansion. Management says it plans to increase the pace of new openings and extensions. (London Stock Exchange)
A branded pet-insurance launch could add a new revenue stream alongside retail and veterinary services. Pets at Home says it is targeting a UK market estimated at about £2bn and planned to launch in 2026. (London Stock Exchange)
Retail profitability remains fragile: FY26 retail margin fell to 2.4% from 5.6% as sales and gross margin weakened. Around one percentage point of Q1 retail growth also came from a timing benefit linked to the PetPlan agreement exit. (London Stock Exchange, London Stock Exchange)
Cash generation has weakened just as the group plans substantial spending and shareholder returns: FY26 free cash flow fell 26% to £61.9m, while FY27 capex and the share buyback are each planned at about £50m. A further deterioration could leave less room to fund both. (London Stock Exchange)
Vet growth may not fully offset retail weakness: Q1 FY27 vet revenue growth slowed to 1.9% from 5% in FY26, and management describes the market as subdued. The full rollout of a new practice-management system is also expected to raise costs. (London Stock Exchange, London Stock Exchange)
Data summarised monthly by Lightyear AI. Last updated on 15 Nov 2026.
PETS Financial Performance
Revenues and expenses
PETS Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing PETS
AllGBPUSDEUR
Fund name | Fund size | £PETS weighting |
|---|---|---|
L&G UK Quality Dividends Equal Weight£LDUK | £81M | 1.88% |
iShares FTSE 250£MIDD | £652M | 0.39% |
Vanguard FTSE 250£VMIG | £569M | 0.35% |
Vanguard FTSE 250£VMID | £1.5B | 0.35% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.7B | 0.07% |
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.